通过破坏蛋白质稳定,ROR2驱动右心室心力衰竭
bioRxiv : the preprint server for biology
|February 20, 2025
概括
右心室衰竭 (RVF) 缺乏治疗方法. 这项研究揭示了ROR2受体破坏蛋白质平衡,驱动RVF,并为这种情况提供潜在的治疗标.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 蛋白质稳定性 蛋白质稳定性
背景情况:
- 右心室衰竭 (RVF) 是一种严重的疾病,没有有效的治疗方法.
- RVF的分子基础在很大程度上是未知的.
- 受体ROR2表达与人类的RVF严重程度相关.
研究的目的:
- 调查ROR2在RVF病变发生过程中的机械作用.
- 确定ROR2是否是RVF的可行的治疗标.
主要方法:
- 在新生小鼠心室肌细胞 (NRVMs) 中操纵ROR2,并使用分子和功能分析进行表征.
- 在体内研究涉及AV9介导的ROR2操纵在RVF的小鼠模型.
- 用体外和体外模型评估心脏功能和蛋白质静止.
主要成果:
- ROR2 失调了蛋白质的翻译和折叠,导致蛋白质通过ubiquitin 蛋白酶体系统 (UPS) 降解.
- 这种蛋白质静止失衡会损害NRVM中的肉核和细胞骨功能.
- 心脏ROR2过度表达在小鼠中诱导了RVF,而ROR2倒置在压力过载RVF模型中部分恢复了功能.
结论:
- 通过破坏细胞蛋白质稳定,ROR2是RVF病变的关键调解者.
- 准ROR2为治疗RVF提供了一个有前途的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Electron Transport Chain: Complex I and II
10.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


